Gates Package — page 1362

conversation Friday afternoon. try to find a time for us to talk next week. yugh it of th to da ugh who afly From: "Lehrman, Sandra \(NIH/NIAID\) [E]" @niaid.nih.gov> To: "Fauci, Anthony \(NIH/NIAID\) [E]" <AFAUCI@niaid.nih.gov>, "Auchincloss, Hugh \ (NIH/NIAID\) [E]" @niaid.nih.gov>, "Dieffenbach, Carl \(NIH/NIAID\) [E]" @niaid.nih.gov>, "Lane, Cliff \(NIH/NIAID\) [E]" @niaid.nih.gov> Subject: Gates/Microbicides Date: Sun, 17 Sep 2006 15:50:38 -0400 Importance: Normal Thought you might be interested in this message relative to our conversation Friday afternoon. Bottom line - Sharon is setting up discussions to explore Gates co funding of MTN studies. I will speak to her tomorrow at the Gates/Forum meeting on Biomedical Approaches to Prevention and keep you up to date. Let me know if you have any specific issues you would like me to raise with Sharon or the Gates representatives. Sandi -----Original Message----- From: Hillier, Sharon L. @mail.magee.edu] Sent: Saturday, September 16, 2006 11:22 AM To: Lehrman, Sandra (NIH/NIAID) [E] Subject: RE: Time to talk Hi Sandi- Just wanted to follow up about finding a time to talk. Looks like between your schedule and mine this month might be tough for a face-to-face meeting but perhaps we could se up a time to talk by phone. Bobbi told me that she would deliver one of our MTN Leadership meeting binders to you this week. I do have a short list of issues to talk about. Probably the most fun is a meeting I have set up with the Gates Foundation at the end of this month to discuss, among other things, the possible co-funding of our planned trial of oral vs vaginal tenofovir under the MTN. Our clinical trial sites will have capacity in mid 2008 and we will have to move fast to identify new PIF for this study. My agenda during the meeting with Gates this time is to briefly outline the MTN and explain what our infratrsucture could provide. I know that Gates is very interested in such a partnership but needs to understand how the Gates money could flow through the DAIDS network structures. I am hoping that our follow-up meeting with Gates would include you and John Mellors, who is the head of our Virology Core and is a major proponent in moving this study forward from the Pittsburgh MTN CORE team. I was at the OAR yesterday co-chairing the WHIN review with Joe Margolick and had the opportunity to meet briefly with Jack Whitescarver after we adjourned. He was also enthusiastic about approaching Gates about this and I told him that I hoped that you could accompany us on our next visit with them. Have a great weekend, Sandi. Soory for the long email but will try to find a time for us to talk next week. Sharon Hillier